NCT06871605

Brief Summary

The aim of this study was to compare the efficacy of ultrasound (US)-guided transversalis fascia plane block (TFP) and ilioinguinal (II) and iliohypogastric (IH) nerve block in the treatment of chronic post-herniorrhaphy inguinal pain (CPIP) refractory to conservative treatments. For this evaluation, a numerical rating scale (NRS) will be used before and after both interventions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

February 11, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 12, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

March 12, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

February 11, 2025

Last Update Submit

March 11, 2025

Conditions

Keywords

UltrasonographyIlioinguinal and iliohypogastric nerveTransversalis Fascia Plane Block

Outcome Measures

Primary Outcomes (1)

  • Numerical rating scale (NRS)

    NRS is a scale that can be used measuring pain. Scores range from 0 (no pain) to 10 (the worst pain)

    Change from baseline to 1st and 3rd month after treatment

Secondary Outcomes (2)

  • procedure-related adverse events

    Change from baseline to 1st and 3rd month after treatment

  • patient satisfaction likert scale

    Change from baseline to 30 minutes after procedure

Study Arms (2)

transversalis fascia plane block group

ACTIVE COMPARATOR

transversalis fascia plane block for chronic postherniorrhaphy inguinal pain

Procedure: ultrasound-guided transversalis fascia plane block

ilioinguinal and iliohypogastric nerve block group

ACTIVE COMPARATOR

ilioinguinal and iliohypogastric nerve block for chronic postherniorrhaphy inguinal pain

Procedure: ultrasound-guided ilioinguinal and iliohypogastric nerve block group

Interventions

With the patient in the lateral decubitus position, an 8-12 Hz linear ultrasound (US) probe is placed transversely over the iliac crest. The external oblique (EO), internal oblique (IO) and transversus abdominis (TA) muscles are identified so that the abdominal muscles are in the field of view. The TA muscle is then advanced posteriorly until it tapers to the thoracolumbar fascia with its aponeurosis adjacent to the quadratus lumborum (QL) muscle. The 22 gauge block needle is advanced in plane with the US probe. After placing the needle tip in the virtual triangular plane between the posterior edge of the TA muscle, the QL and the underlying transversalis fascia, 4 mL of 0.5% bupivacaine + 2 mL of a total of 8 mg dexamethasone + 4 mL of saline are injected for a total volume of 10 mL.

transversalis fascia plane block group

With the patient in the supine position, an 8-12 Hz linear ultrasound (US) probe is placed medial and cephalal to the anterior superior iliac spine (ASIS), transversely between the ASIS and the umbilicus. The external oblique (EO), internal oblique (IO) and transversus abdominis (TA) muscles are identified so that the abdominal muscles are in the field of view. The II-IH nerves are hyperechogenic in the fascial plane between the IO and TA muscles. A 22 gauge block needle is advanced in plane with the US probe. When the needle tip is advanced to the II and IH nerves, 4 mL of 0.5% bupivacaine + 2 mL total 8 mg dexamethasone + 4 mL saline is injected for a total volume of 10 mL.

ilioinguinal and iliohypogastric nerve block group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Complaints of inguinal pain \>12 weeks post-herniorrhaphy surgery
  • \>18 years of age
  • Failure of conservative pain management

You may not qualify if:

  • Other causes of inguinal pain (haematoma, infection, tubo-ovarian disease, abscess, etc., gynaecological, urological and organic pathologies after inguinal hernia, etc.)
  • Pregnancy
  • Coagulopathy, antiaggregant/anticoagulant/antiplatelet use
  • Unstable psychiatric illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diskapi Training and Research Hospital

Ankara, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Hernia, Inguinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Gevher Rabia Genc Perdecioğlu

    Diskapi TRH

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Supervisor Investigator

Study Record Dates

First Submitted

February 11, 2025

First Posted

March 12, 2025

Study Start

February 11, 2025

Primary Completion

August 1, 2025

Study Completion

October 1, 2025

Last Updated

March 12, 2025

Record last verified: 2025-03

Locations